Lyra Therapeutics Inc (NASDAQ: LYRA) is 0.87% higher on its value in year-to-date trading and has touched a low of $0.16 and a high of $6.79 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LYRA stock was last observed hovering at around $0.21 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.21, the stock is 9.40% and 7.30% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.5 million and changing -0.86% at the moment leaves the stock -40.76% off its SMA200. LYRA registered -95.68% loss for a year compared to 6-month loss of -27.36%. The firm has a 50-day simple moving average (SMA 50) of $0.1941 and a 200-day simple moving average (SMA200) of $0.35149.
The stock witnessed a 10.16% gain in the last 1 month and extending the period to 3 months gives it a -24.29%, and is 11.34% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.26% over the week and 7.19% over the month.
Lyra Therapeutics Inc (LYRA) has around 88 employees, a market worth around $13.63M and $1.47M in sales. Profit margin for the company is -6635.76%. Distance from 52-week low is 28.12% and -96.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-187.93%).
with sales reaching $206k over the same period.The EPS is expected to shrink by -5.36% this year, but quarterly earnings will post -2.21% year-over-year. Quarterly sales are estimated to grow 41.10% in year-over-year returns.
Lyra Therapeutics Inc (LYRA) Top Institutional Holders
74.0 institutions hold shares in Lyra Therapeutics Inc (LYRA), with institutional investors hold 51.46% of the company’s shares. The shares outstanding are 65.46M, and float is at 53.69M with Short Float at 3.98%. Institutions hold 51.15% of the Float.
The top institutional shareholder in the company is PERCEPTIVE ADVISORS LLC with over 12.76 million shares valued at $3.53 million. The investor’s holdings represent 19.4892% of the LYRA Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 4.77 million shares valued at $1.32 million to account for 7.4562 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 2.83 million shares representing 4.4211% and valued at over $0.78 million, while SAMSARA BIOCAPITAL, LLC holds 4.2473 of the shares totaling 2.78 million with a market value of $0.77 million.
Lyra Therapeutics Inc (LYRA) Insider Activity
#####
